Establishment of immunoassay for detecting HPV16 E6 and E7 RNA

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ding, Sen ^a   Qian, Steven Y ^b   Zhang, Yang ^a   Wu, Wenlei ^c   Lu, Gensheng ^d   Lu, Yan ^a   Feng, Xiujing ^a   Li, Li ^a   Shen, Pingping ^a  

^a NANJING UNIVERSITY   (China)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; VIRUS RNA;

HUMAN; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

DNA-BINDING PROTEINS; HUMANS; IMMUNOASSAY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 84940877678     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13686     Document Type: Article

References (42)

1. Hausen, H. Z., Meinhof, W., Scheiber, W., Bornkamm, G. W. Attempts to detect virus?specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 13, 650-656 (1974).
2. Zur Hausen, H. in Current topics in microbiology and immunology (eds Arber, W. et al.) 1-30 (Springer, 1977).
3. De Villiers, E., Fauquet, C., Broker, T. R., Bernard, H., Zur Hausen, H. Classification of papillomaviruses. Virology 324, 17-27 (2004).
4. Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., Ward, E. M. The global burden of cancer: priorities for prevention. Carcinogenesis 31, 100-110 (2010).
5. Voevodin, A. F., Marx, P. A. Papillomaviruses. Simian Virology. 389-396, doi: 10.1002/9780813809793.ch19 (2009).
6. Munoz, N. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 348, 518-527 (2003).
7. Armstrong, E. P. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. Journal of managed care pharmacy: JMCP 16, 217 (2010).
8. Doorbar, J. et al. The biology and life-cycle of human papillomaviruses. Vaccine 30, F55-F70 (2012).
9. Zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350 (2002).
10. Pett, M., Coleman, N. Integration of high?risk human papillomavirus: a key event in cervical carcinogenesis? The Journal of pathology 212, 356-367 (2007).
11. Woodman, C. B., Collins, S. I., Young, L. S. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7, 11-22 (2007).
12. Brink, A. A., Snijders, P. J., Meijer, C. J. HPV detection methods. Dis Markers 23, 273-281 (2007).
13. Poljak, M., Kocjan, B. J. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert review of anti-infective therapy 8, 1139-1162 (2010).
14. Wolcott, M. J. Advances in nucleic acid-based detection methods. Clin Microbiol Rev 5, 370-386 (1992).
15. Gravitt, P. E. et al. New technologies in cervical cancer screening. Vaccine 26, K42-K52 (2008).
16. Molijn, A., Kleter, B., Quint, W., van Doorn, L. J. Molecular diagnosis of human papillomavirus (HPV) infections. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 32, S43 (2005).
17. Einstein, M. H. et al. Clinical validation of the Cervista? HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Gynecol Oncol 118, 116-122 (2010).
18. Huang, S. et al. Principles and analytical performance of Abbott RealTime High Risk HPV test. J Clin Virol 45, S13-S17 (2009).
19. Castle, P. E. et al. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol 47, 3344-3347 (2009).
20. Stoler, M. H. et al. High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology Results From the ATHENA HPV Study. Am J Clin Pathol 135, 468-475 (2011).
21. Luft, F. et al. Detection of integrated papillomavirus sequences by ligation?mediated PCR (DIPS?PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92, 9-17 (2001).
22. Klaes, R. et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59, 6132-6136 (1999).
23. Carozzi, F. M. et al. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting. J Clin Microbiol 49, 1446-1451 (2011).
24. Ronco, G. et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer I 100, 492-501 (2008).
25. Rong, S. J., Shrestha, R., Pradhan, D., Linka, K., Mally, J. Clinical significance of thin cytology and HPV DNA test in diagnosing cervical disease. Gynecology 1, http://dx.doi.org/10.7243/2052-6210-1-7 (2013).
26. Nakazato, H. Fractionation and characterization of antibodies elicited by. vphi. X174 deoxyribonucleic acid-ribonucleic acid hybrid. Biochemistry-Us 19, 2835-2840 (1980).
27. Carrico, R. J. inventors; Miles, Inc., assignee. Monoclonal antibody specific for DNA.RNA hybrids. United States patent US 4,833,084. 1989 May 23.
28. Boguslawski, S. J. et al. Characterization of monoclonal antibody to DNA? RNA and its application to immunodetection of hybrids. J Immunol Methods 89, 123-130 (1986).
29. Phillips, D. D. et al. The sub?nanomolar binding of DNA-RNA hybrids by the single?chain Fv fragment of antibody S9. 6. J Mol Recognit 26, 376-381 (2013).
30. Diao, M. et al. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines. Life Sci 127, 46-52 (2015).
31. Levin, C. E. et al. Cost?effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high?risk region of China. Int J Cancer 127, 1404-1411 (2010).
32. Gravitt, P. E., Belinson, J. L., Salmeron, J., Shah, K. V. Looking ahead: A case for human papillomavirus testing of self?sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 129, 517-527 (2011).
33. Murphy, P. G. et al. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath™ preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR. J Virol Methods 156, 138-144 (2009).
34. Yehle, C. O. et al. A solution hybridization assay for ribosomal RNA from bacteria using biotinylated DNA probes and enzymelabeled antibody to DNA: RNA. Mol Cell Probe 1, 177-193 (1987).
35. Viscidi, R. P., O'Meara, C., Farzadegan, H., Yolken, R. Monoclonal antibody solution hybridization assay for detection of human immunodeficiency virus nucleic acids. J Clin Microbiol 27, 120-125 (1989).
36. Coutlee, F., Viscidi, R. P., Yolken, R. H. Comparison of colorimetric, fluorescent, and enzymatic amplification substrate systems in an enzyme immunoassay for detection of DNA-RNA hybrids. J Clin Microbiol 27, 1002-1007 (1989).
37. Bobo, L., Coutlee, F., Yolken, R. H., Quinn, T., Viscidi, R. P. Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay. J Clin Microbiol 28, 1968-1973 (1990).
38. Casebolt, D. B., Stephensen, C. B. Monoclonal antibody solution hybridization assay for detection of mouse hepatitis virus infection. J Clin Microbiol 30, 608-612 (1992).
39. Fliss, I. et al. Production and characterization of anti-DNA-RNA monoclonal antibodies and their application in Listeria detection. Appl Environ Microb 59, 2698-2705 (1993).
40. Nakazato, H. Radioimmunoassay of an antibody to ? X174 DNA? RNA hybrid. Anal Biochem 98, 74-80 (1979).
41. Aotsuka, S., Okawa, M., Ikebe, K., Yokohari, R. Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes. J Immunol Methods 28, 149-162 (1979).
42. Zouali, M., Stollar, B. D. A rapid ELISA for measurement of antibodies to nucliec acid antigens using UV-treated polystyrene microplates. J Immunol Methods 90, 105-110 (1986).